There Is No Vaccine For Deadly Hantavirus, But This Scientist Is Working On One

There is nary vaccine for deadly hantavirus, but this intelligence is moving connected one

Virologist Jay Hooper is processing a vaccine for nan uncommon rodent microorganism down an outbreak connected a cruise ship

By Mohana Basu & Nature magazine

Arman Onal/Anadolu via Getty Images

An outbreak of hantavirus onboard nan cruise vessel MV Hondius has thrown a spotlight connected nan uncommon but deadly infection and nan deficiency of options for curen and prevention.

Three group who were connected nan vessel person tested affirmative for nan virus, including 1 rider who died. Among different 5 group pinch suspected infections, 2 person died.

Hantavirus typically spreads done nan air, successful particles from rodent urine, droppings aliases saliva. But immoderate strains tin occasionally dispersed betwixt group who are successful adjacent contact. One of these strains, called Andes virus, is responsible for an ongoing outbreak successful Argentina, and World Health Organization director-general Tedros Adhanom Ghebreyesus has confirmed that nan passengers were infected pinch this strain, for which location are nary circumstantial treatments aliases vaccines. Scientists fishy that immoderate of nan travellers mightiness person been infected successful Argentina earlier boarding nan cruise. Although hantavirus infections are rare, immoderate strains person a fatality complaint of up to 50%.

On supporting subject journalism

If you're enjoying this article, see supporting our award-winning publicity by subscribing. By purchasing a subscription you are helping to guarantee nan early of impactful stories astir nan discoveries and ideas shaping our world today.

For much than 3 decades, Jay Hooper, a virologist astatine nan US Army Medical Research Institute of Infectious Diseases successful Frederick, Maryland, has been moving to create a vaccine against respective strains of hantavirus that tin infect people, including nan Andes virus.

He talks to Nature astir why these vaccines stay elusive.

Is this outbreak a motion that nan consequence of infection pinch hantavirus is increasing?

Some group person suggested, and I person said it before, that ambiance alteration could change rodent populations and summation nan number of group surviving successful aliases entering areas wherever these rodents are present. That mightiness summation lawsuit numbers.

As pinch immoderate zoonotic microorganism — an animal-borne microorganism that spills into humans — nan business is inherently unpredictable. Look astatine what happened pinch monkeypox virus.

How agelong has your squad been moving connected hantavirus vaccines?

Because these viruses are rodent-borne and airs a consequence to troops connected nan ground, nan subject has agelong wanted a vaccine. I activity astatine nan US Army Medical Research Institute of Infectious Diseases, which has been moving connected hantavirus vaccines since astir nan 1980s.

I joined successful nan squad successful nan 1990s. At that time, caller hantaviruses causing hantavirus pulmonary syndrome (HPS) appeared: nan Sin Nombre microorganism successful nan Four Corners region of nan United States and nan Andes microorganism successful South America. The laboratory started processing vaccines for these strains.

A cardinal beforehand of our squad has been processing hamster models of a lethal illness very akin to quality HPS. This provides a realistic animal exemplary to trial vaccines and therapeutics.

We person done shape 1 objective tests of vaccines for Andes microorganism and 2 different strains, Hantaan and Puumala.

In humans, nan Andes DNA vaccine induces neutralizing antibodies, which are important for protection, truthful nan vaccine looks promising. However, it requires astatine slightest 3 doses (prime positive 2 boosts) alternatively of a azygous changeable aliases elemental prime–boost regimen.

We are now taking neutralizing antibodies from vaccinated humans and testing them arsenic a vaccine successful nan hamster model; results will beryllium reported successful a early publication.

Because quality cases of Andres microorganism are uncommon and geographically scattered, location is nary evident region to tally a classical shape 3 efficacy trial, truthful to meet nan requirements for licensing nan vaccine requires much imaginative approaches. Hence nan accent connected neutralizing antibodies arsenic a correlate of protection.

Another awesome obstruction for hantavirus vaccines is backing for precocious development.

If this vaccine were licensed, who would person it?

Likely recipients would beryllium group walking to regions wherever nan microorganism is endemic; outdoorspeople and others pinch precocious vulnerability to rodent habitats; subject personnel; and workers successful fields aliases environments pinch dense rodent interaction and higher risk.

Overall, nan commercialized marketplace would beryllium small, and it is not an charismatic vaccine marketplace from a axenic business perspective.

What other are you moving on?

We are processing antibody‑based products arsenic imaginable treatments.

By vaccinating genetically modified cows that nutrient afloat quality antibodies, we person generated a potent antibody product, called SAB-163. It tin protect animal models from Andes microorganism and 3 different hantavirus strains. But it has not yet entered a shape 1 quality trial.

We are besides exploring different vaccine technologies that could move overmuch faster if location were existent demand. The existing nucleic acerb vaccine activity is very translatable to mRNA platforms. COVID‑19 showed really quickly mRNA vaccines tin beryllium developed.

Right now, we are pushing from nan investigation side, but location is nary beardown outer pull, truthful advancement is slower than it could be. It is frustrating — for illustration pushing a stone up a elevation for years.